首页> 美国卫生研究院文献>Biochemistry and Biophysics Reports >Relative proteome quantification of alpha beta gamma and delta globin chains in early eluting peaks of Bio-Rad variant II® CE-HPLC of hemoglobin from healthy and beta-thalassemia subjects in Malaysia
【2h】

Relative proteome quantification of alpha beta gamma and delta globin chains in early eluting peaks of Bio-Rad variant II® CE-HPLC of hemoglobin from healthy and beta-thalassemia subjects in Malaysia

机译:来自马来西亚健康和β地中海贫血受试者的血红蛋白Bio-Rad变体II®CE-HPLC早期洗脱峰中αβγ和δ珠蛋白链的相对蛋白质组定量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This is the first report of QQQ-mass spectrometric identification and quantification of the Hb subunits, alpha, beta, delta and gamma globin peptides, derived from enzymatic-digestion of proteins in the early unknown peaks of the Bio-Rad cation-exchange chromatography of haemoglobin. The objectives were to assess the relationship of the quantity of the free alpha, beta, delta and gamma globin chains with the phenotypic diversity of beta-thalassaemias (β-thal). The results demonstrate that the pools of free globin chains in red blood cells were correlating with the severity of the disease in patients with different phenotypes of β-thal. The mechanism and the regulation of synthesis of free globin chains pool in a normal individual and in patients with different β-thal phenotypes could arise from several mechanisms which will require further investigation. The role of the free globin pool in patients with β-thal for development of novel therapeutic approaches based on these potential targets requires further investigation. Pertinent biomarkers improves the diagnosis of the β-thal, especially in low-income countries where they are most common and allows more effective therapeutic intervention leading to more successful therapeutic outcome.
机译:这是QQQ质谱鉴定和定量Hb亚基,α,β,δ和γ珠蛋白肽的第一份报告,该酶衍生自酶解法在Bio-Rad阳离子交换层析的早期未知峰中的蛋白质。血红蛋白。目的是评估游离α,β,δ和γ珠蛋白链的数量与β地中海贫血(β-thal)的表型多样性之间的关系。结果表明,在具有不同β-β-表型表型的患者中,红细胞中的游离球蛋白链库与疾病的严重程度相关。正常个体和具有不同β-thal表型的患者中游离球蛋白链库的合成机制和调节可能来自多种机制,需要进一步研究。游离球蛋白池在β-thal患者中基于这些潜在靶标开发新治疗方法的作用尚需进一步研究。相关的生物标志物可改善β-thal的诊断,尤其是在最常见的低收入国家/地区,并可以进行更有效的治疗干预,从而获得更成功的治疗结果。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号